Shinji Kishimoto

Shinji Kishimoto

Auto-generated profile, based on publicly available information

Shinji Kishimoto

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
SKShinji Kishimoto
Shinji Kishimoto
MKMasato Kajikawa
Masato Kajikawa
TMTatsuya Maruhashi
Tatsuya Maruhashi
YIYumiko Iwamoto
Yumiko Iwamoto
TMTakeshi Matsumoto
Takeshi Matsumoto
YHYukihito Higashi
Yukihito Higashi

1 June 2016 in Atherosclerosis
Verified
Journal Article
Closed access
MKMasato Kajikawa
Masato Kajikawa
TMTatsuya Maruhashi
Tatsuya Maruhashi
TMTakeshi Matsumoto
Takeshi Matsumoto
YIYumiko Iwamoto
Yumiko Iwamoto
AIAkimichi Iwamoto
Akimichi Iwamoto
YHYukihito Higashi
Yukihito Higashi

25 April 2024 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MKMasato Kajikawa
Masato Kajikawa
TMTatsuya Maruhashi
Tatsuya Maruhashi
SKShinji Kishimoto
Shinji Kishimoto
TYTakayuki Yamaji
Takayuki Yamaji
THTakahiro Harada
Takahiro Harada
YHYukihito Higashi
Yukihito Higashi
Context A Body Shape Index (ABSI) has been reported to have associations with cardiovascular risk factors. However, there is no information on the association between ABSI and incidence of cardiovascular events. Methods We investigated the associations between ABSI and first major cardiovascular events (death from cardiovascular disease, nonfatal acute coronary syndrome, and nonfatal stroke) in 1857 subjects from the database of Flow-Mediated Dilation Japan registry and from Hiroshima University Vascular Function registry. Results The areas under the curves of ABSI to predict the first major cardiovascular events were superior to BMI (men: P = .032, women: P = .015) and waist circumference in women (men: P = .078, women: P = .002). The subjects were divided into 2 groups based on the cutoff value of ABSI for predicting first major cardiovascular events: a low ABSI group (<0.0822 in men and <0.0814 in women) and a high ABSI group (≥0.0822 in men and ≥0.0814 in women). During a median follow-up period of 41.6 months, 56 subjects died (23 from cardiovascular causes), 16 had nonfatal acute coronary syndrome, and 14 had nonfatal stroke. The Kaplan-Meier curves for first major cardiovascular events were significantly different between the 2 groups (men, P < .001; women, P < .001). Multivariate analysis revealed that high ABSI remained an independent predictor of first major cardiovascular events (men: hazard ratio, 2.33; 95% CI, 1.07 to 5.06; P = .033; women: hazard ratio, 8.33; 95% CI, 1.06 to 65.49; P = .044). Conclusion High ABSI is independently associated with incidence of cardiovascular events. ABSI calculation should be performed for evaluation of risk of cardiovascular events.

1 January 2018 in Atherosclerosis
Verified
Journal Article
Closed access
TMTatsuya Maruhashi
Tatsuya Maruhashi
JSJunko Soga
Junko Soga
NFNoritaka Fujimura
Noritaka Fujimura
NINaomi Idei
Naomi Idei
SMShinsuke Mikami
Shinsuke Mikami
YHYukihito Higashi
Yukihito Higashi

8 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HHHaruki Hashimoto
Haruki Hashimoto
TMTatsuya Maruhashi
Tatsuya Maruhashi
TYTakayuki Yamaji
Takayuki Yamaji
THTakahiro Harada
Takahiro Harada
Yiming HanYiming Han
Yiming Han
YHYukihito Higashi
Yukihito Higashi
It is established that smoking is a major risk factor of atherosclerosis. Endothelial dysfunction occurs in the initial step in the pathogenesis of atherosclerosis and plays a critical role in the development of atherosclerosis. The purpose of this study was to evaluate the association between smoking status and endothelial function in detail in men. We measured flow-mediated vasodilation (FMD) in 2209 Japanese men including 1181 men who had never smoked and 1028 current smokers. All of the participants were divided into five groups by smoking pack-years: never smoker group (= 0), light smoker group (> 0 to 10), moderate smoker group (> 10 to 20), heavy smoker group (> 20 to 30) and excessive smoker group (> 30). FMD significantly decreased in relation to pack-years (6.6 ± 3.4% in the never smoker group, 6.8 ± 3.0% in the light smoker group, 6.5 ± 2.9% in the moderate smoker group, 5.9 ± 2.9% in the heavy smoker group, and 4.9 ± 2.7% in the excessive smoker group; P < 0.001). After adjustment for age (≥ 65 years), body mass index, systolic blood pressure, low-density lipoprotein cholesterol, glucose, and year of recruitment, FMD was significantly smaller in the excessive smoker group than in the never smoker group as a reference group (OR 1.95, 95% CI 1.42 to 2.67; P < 0.001). These findings suggest that FMD decreases with an increase in the number of cigarettes smoked and that excessive smoking is associated with endothelial dysfunction. Cigarette smoking is harmful to vascular function in men who are heavy smokers.

21 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMShogo Matsui
Shogo Matsui
MKMasato Kajikawa
Masato Kajikawa
EHEisuke Hida
Eisuke Hida
TMTatsuya Maruhashi
Tatsuya Maruhashi
YIYumiko Iwamoto
Yumiko Iwamoto
YHYukihito Higashi
Yukihito Higashi
We investigated (1) the relationship between low-density lipoprotein cholesterol (LDL-C) and vascular function in patients receiving and those not receiving statin therapy and (2) optimal level of LDL-C for maintenance of vascular function. Flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) were inversely correlated with LDL-C in the 957 statin naïve subjects but not in the 392 subjects receiving statin therapy. In statin naïve subjects, non-high LDL-C (≤100 mg/dL) was independently associated with a decrease in adjusted odds ratio of the low tertile of FMD (OR: 0.62, 95% CI: 0.45–0.85; P = 0.003) and NID (OR: 0.69, 95% CI: 0.50–0.96; P = 0.03). Adjusted odds ratio of the low tertile of FMD was significantly lower in the low LDL-C group (≤70 mg/dL) (OR: 0.47, 95% CI, 0.27–0.81; P = 0.006) and in the moderate LDL-C group (70.1–100 mg/dL) (OR: 0.66, 95% CI, 0.48–0.94; P = 0.02) than in the high LDL-C group (>100 mg/dL). There was no significant difference in FMD between the low LDL-C group and moderate LDL-C group. There were significant relationships of FMD and NID with LDL-C levels in statin naïve subjects. In a general population, LDL-C of ≤100 mg/dL may be the optimal target level for maintenance of endothelial function.